Updated August 2026. The United Arab Emirates has established itself as the Gulf region’s premier hub for medical device distribution, with total imports exceeding AED 8.5 billion in 2025 and growing at a compound annual rate of 7.2%. The Ministry of Health and Prevention (MOHAP) governs medical device registration through the Medical Devices Registration System (MDRS), while the Dubai Health Authority (DHA), the Department of Health Abu Dhabi (DOH), and free zone authorities including JAFZA Healthcare Zone and Dubai Healthcare City (DHCC) each maintain additional licensing and facility requirements. Setting up a compliant medical device distribution company in the UAE demands careful navigation of federal registration, emirate-level permits, import clearance, and post-market surveillance obligations. This guide covers every step—from company formation and MOHAP registration to warehouse compliance and ongoing renewal—providing the regulatory data and cost figures you need to plan and execute your UAE market entry in 2026.
- MOHAP medical device registration fees: Class I AED 500, Class IIa AED 2,000, Class IIb AED 3,000, Class III AED 4,000–5,000 per device listing
- Mainland distributor setup costs range from AED 15,000–35,000 (trade license + DHA permit + admin); first-year total with warehouse AED 80,000–200,000
- JAFZA Healthcare Zone provides zero import duty, 100% foreign ownership, and GDP-compliant bonded warehousing with 24-hour customs clearance
- A UAE Authorized Representative must be formally appointed by the manufacturer before MOHAP accepts any registration application
- Class III high-risk devices require pre-market approval meetings and clinical data submission, extending timelines to 90–180 business days
UAE Medical Device Market Overview 2026
The UAE medical device sector is driven by a rapidly expanding hospital network, an ageing expatriate population, strong medical tourism inflows, and the government’s Vision 2031 healthcare spending targets. Total healthcare expenditure in the UAE reached AED 79 billion in 2024, with medical devices accounting for roughly 11% of that figure. Major end-users include Cleveland Clinic Abu Dhabi, Mediclinic Middle East, NMC Health, Sheikh Khalifa Medical City, and hundreds of private specialty clinics and diagnostic centres. The UAE imports devices primarily from the United States, Germany, Japan, China, and South Korea; premium American and European brands dominate surgical robotics, cardiac devices, and diagnostic imaging, while Chinese and South Korean manufacturers have captured significant share in physiotherapy equipment, patient monitoring systems, and ophthalmic instruments.
The government’s unified MOHAP MDRS platform, overhauled in 2022, has streamlined the registration process: over 47,000 device listings are now active on the system. All devices sold or distributed in the UAE must carry a valid MOHAP registration number on commercial invoices; devices found without registration are subject to immediate seizure and fines up to AED 500,000 per violation under the UAE Medical Devices Law.
MOHAP Medical Device Registration Process
Registration is initiated by the UAE Authorized Representative (AR)—a locally licensed company (distributor, importer, or regulatory consultancy) formally appointed by the overseas manufacturer via a signed Manufacturer Appointment Letter. The AR bears full regulatory responsibility for the device throughout its UAE lifecycle. The standard application package submitted through MDRS must include: ISO 13485 certificate or equivalent QMS certification; CE mark, FDA 510(k), or equivalent international approval; technical file or design dossier summary; Instructions for Use in English and Arabic; device labelling samples; Certificate of Free Sale (CFS) attested by the UAE Embassy in the country of manufacture; and the signed AR appointment letter.
MOHAP issues Deficiency Letters for incomplete applications, requiring response within 30 business days. Processing times under the current system: Class I — 30 business days; Class IIa/IIb — 45–75 business days; Class III — 90–180 business days. Registrations are valid three years, renewable at 50% of the original fee. IVD devices carry a separate fee schedule: General Purpose IVD AED 1,000; Self-Testing IVD AED 2,500; High-Risk IVD AED 4,000.
Device Classification: Class I, II, and III
The UAE follows the IMDRF risk-based classification framework, aligned with EU MDR and GHTF guidance. Understanding the class of each product in your portfolio is critical because it determines registration fees, documentation requirements, and timelines.
Class I (Low Risk): Non-invasive, no energy dependency for primary function. Examples: bandages, examination gloves, tongue depressors, crutches. Registration fee AED 500. Basic technical file plus Declaration of Conformity required. 30-day processing target.
Class IIa (Medium-Low Risk): Short-term invasive or active diagnostic devices. Examples: surgical gloves, hearing aids, ultrasound devices, dental drills, compression stockings. Fee AED 2,000. Full technical documentation and performance evidence required. 45–60 days.
Class IIb (Medium-High Risk): Long-term use, active therapeutic, or medicine-administering devices. Examples: ventilators, dialysis machines, surgical lasers, infusion pumps. Fee AED 3,000. Detailed clinical data and post-market clinical follow-up plan required. 60–75 days.
Class III (High Risk): Life-sustaining, implantable, or direct cardiac/CNS contact devices. Examples: cardiac pacemakers, coronary stents, cochlear implants, spinal implants. Fee AED 4,000–5,000. Pre-market approval meeting, extensive clinical evaluation report, and PMS plan mandatory. 90–180 days.
Business Setup Options for Medical Device Distributors
Four primary pathways exist for foreign investors entering UAE medical device distribution. A Mainland LLC under the Department of Economic Development offers the broadest market reach—direct supply to all government and private facilities across all seven emirates. Since the 2021 Commercial Companies Law amendment, 100% foreign ownership is permitted in most commercial activities including healthcare distribution, removing the historical 51% UAE national shareholder requirement. An LLC requires a physical office or warehouse, a DED trade license, and a DHA healthcare distribution permit for Dubai operations (or equivalent DOH/MOH permits for other emirates).
A JAFZA Healthcare Zone company suits high-volume importers and re-exporters targeting the wider GCC, with zero import duty and bonded warehousing. A DHCC entity suits distributors who also engage with DHCC’s healthcare providers and want streamlined access to DHCC’s clinical community. A foreign branch office requires a UAE national service agent but allows the parent company’s full commercial scope without a new local entity.
JAFZA Healthcare Zone: The Premium Distribution Hub
JAFZA Healthcare Zone, adjacent to Jebel Ali Port and Al Maktoum International Airport, is the UAE’s leading hub for pharmaceutical and medical device storage, handling, and GCC re-export. Key advantages: zero import duty on inbound goods (vs 5% GCC Common External Tariff for mainland); 100% foreign ownership; zero corporate income tax; full profit/capital repatriation; GDP-compliant cold-chain warehousing; and average customs clearance under 24 hours for AEO-certified companies.
JAFZA setup costs: annual business license AED 10,000–15,000; warehouse rental from AED 80/sqm/year (minimum 200 sqm regulated unit); one-time registration AED 2,000–5,000; legal and admin AED 5,000–10,000. First-year total: AED 35,000–70,000 (minimum facility), rising to AED 80,000–150,000 for a 1,000+ sqm bonded facility. JAFZA companies supply mainland UAE customers via a mainland sales NOC or through an appointed mainland distributor partner.
| Setup Type | Foreign Ownership | Import Duty | License Cost AED/yr | Market Access | Best For |
|---|---|---|---|---|---|
| Mainland LLC | 100% (2021 law) | 5% | 15,000–25,000 | All UAE + GCC | Full UAE distribution |
| JAFZA Healthcare Zone | 100% | 0% (re-export) | 10,000–15,000 | GCC (NOC for mainland) | Import-heavy, re-export |
| DHCC Entity | 100% | 5% | 12,000–18,000 | DHCC + mainland NOC | Clinical demos + supply |
| DAFZA (Airport FZ) | 100% | 0% (re-export) | 8,000–12,000 | GCC (NOC for mainland) | Air-freight-dominant imports |
| Foreign Branch Office | 100% | 5% | 20,000–35,000 | All UAE + GCC | Manufacturer subsidiary |
Licensing Costs and Timeline
A realistic first-year cost breakdown for a mainland Dubai medical device distributor: DED trade license AED 8,000–12,000; DHA healthcare distribution permit AED 3,000–5,000; MOHAP distributor registration AED 3,000; establishment card and immigration file AED 1,500–2,500; MOA preparation and attestation AED 2,000–4,000; customs import file AED 500–1,000. One-time government fees total: AED 18,000–27,500. Warehouse lease (200 sqm, temperature-monitored) AED 40,000–80,000/year. MOHAP registration fees for a mixed portfolio of 30 devices: AED 40,000–60,000 in Year 1. Total first-year operating budget for a small-to-medium distributor: AED 150,000–350,000.
Timeline: company incorporation 2–4 weeks; DHA permit application and facility inspection 3–6 weeks; MOHAP Class I/II registrations 30–75 business days; first shipment to first sale 4–8 months total.
Import Duties, Customs, and Documentation
Medical devices imported to UAE mainland from outside the GCC attract a 5% import duty under the GCC Common External Tariff, calculated on CIF value. Certain categories of essential medical equipment under MOHAP Circular 43/2019 qualify for Federal Customs Authority duty exemption with prior approval. Required documentation per shipment: commercial invoice showing MOHAP registration number; packing list with lot numbers and expiry dates; bill of lading or airway bill; certificate of origin; MOHAP device registration certificate copy; DHA import permit for restricted categories; and a temperature monitoring log for cold-chain products. First-time importers must submit UAE Embassy-attested supplier registration and distributorship agreement documents.
Post-Market Surveillance and Ongoing Compliance
The UAE Medical Devices Law requires all AR holders to maintain an active post-market surveillance (PMS) system. Serious adverse events (SAEs) must be reported to MOHAP’s Pharmacovigilance and Medical Device Safety Section within 15 calendar days. Field Safety Corrective Actions (device recalls) must be coordinated with MOHAP and communicated to all consignees within 48 hours of the recall decision. Full lot-traceability records must be retained for a minimum of five years after the last sale of each batch. Annual compliance reports for Class III devices are due to MOHAP by 31 March each year. Failure to report an SAE constitutes a Category A violation with fines of AED 50,000–200,000.
What is the minimum capital requirement to start a medical device distribution company in UAE?
There is no statutory minimum capital for a mainland LLC under the 2021 UAE Commercial Companies Law. JAFZA and DHCC free zones require a minimum share capital of AED 50,000 for FZE or FZCO structures. Practically, first-year budgets covering setup, MOHAP registrations, warehouse, staff, and initial inventory range from AED 200,000 to AED 500,000 for a mid-sized distribution operation.
How long does MOHAP medical device registration take in 2026?
MOHAP target processing times under the current MDRS system are 30 business days for Class I devices, 45–60 business days for Class II, and 90–180 business days for Class III high-risk devices. Submitting a complete documentation package in the first attempt and responding promptly to any MOHAP deficiency letters are the most effective ways to stay within the published timelines.
Can a foreign investor own 100% of a medical device distribution company in UAE?
Yes. The 2021 amendment to the UAE Federal Commercial Companies Law allows 100% foreign ownership in most commercial activities on the mainland, including healthcare product distribution. UAE national shareholders are no longer required in most distribution activities. Free zone companies have always permitted 100% foreign ownership, with no restrictions.
Does a JAFZA medical device company need a separate MOHAP device registration?
Yes. MOHAP device registration is a product-level requirement that applies regardless of where the distributing company is licensed. Whether established in JAFZA, DHCC, or mainland UAE, every device imported or supplied into the UAE market must carry a valid MOHAP registration number. JAFZA provides logistical advantages but does not substitute for MOHAP compliance obligations.
Are medical devices subject to VAT in the UAE?
Most medical devices are subject to 5% UAE VAT. However, “qualifying medical equipment” as defined under Cabinet Decision No. 52 of 2017—including human blood, human organs for transplant, and specific approved devices—may be zero-rated. Distributors should obtain a formal ruling from the Federal Tax Authority (FTA) before assuming zero-rating applies to their specific device categories.